1-(4-Bromo-phenyl)-5-methyl-1H-pyrazole-4-carboxylic acid, = 98.5% (HPLC), 250mg

3-Aminopropan-1-ol hydrochloride, 98%, 25g

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(6-methoxypyridin-3-yl)propanoic acid, 98%, 1g

Anti-Influenza A Virus Hemagglutinin H3 Monoclonal Antibody (Preservative : 0.05% NaN3, Stabilizer : 1% BSA)0.2mL

1-Ethyl-3-methyl-4-nitro-1H-pyrazole-5-carboxylic acid, 85.0%, 5g

3-Aminoquinoline>99.0%(GC)(T)5g

2-(2-(3-Aminopropoxy)ethoxy)ethan-1-ol, 97%, 5g

4-(PIPERAZIN-1-YL)-1H-INDAZOLE HCL, 95%, 250mg

3,4-Diethyl-pyrrol, 98.0%, 5g

Ethanol, 2-[4-[(1Z)-4-chloro-1,2-diphenyl-1-buten-1-yl]phenoxy]-, 98%, 50mg

4H-Furo[3,2-b]pyrrole-5-carboxylic acid, 98.0%, 500mg

Plan 4x/0.10 infinity corrected objective

2-(2-Chlorophenyl)-2-methylpropanenitrile, 95%, 250mg